Excision BioTherapeutics

Excision BioTherapeutics is a private company dedicated to developing advanced gene-editing therapies to address the medical needs of life-threatening diseases caused by viral infections. In addition to CRISPR-based HIV therapy, the company's R&D pipeline includes using CRISPR technology to eliminate the hepatitis B virus (HBV), herpes simplex virus (HSV), JC polyomavirus (JCV), and the coronavirus (SARS-CoV-2).